Detection of Latent Retroviruses in Vaccine-related Cell Substrates: Investigation of RT Activity Produced by Chemical Induction of Vero Cells

References

1. 1.↵
   1. Khan A. S.

   Testing considerations for novel cell substrates: a regulatory perspective. PDA J. Pharm. Sci. Technol. 2010, 64 (5), 426–431.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Khan A. S.

   Regulatory considerations for raw materials used in biological products. PDA J. Pharm. Sci. Technol. 2010, 64 (5), 451–457.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Petricciani J.

   Animal cell substrates: back to the future. PDA J. Pharm. Sci. Technol. 2010, 64 (5), 375–378.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Khan A. S.,
   2. Ma W.,
   3. Ma Y.,
   4. Kumar A.,
   5. Williams D. K.,
   6. Muller J.,
   7. Ma H.,
   8. Galvin T. A.

   Proposed algorithm to investigate latent and occult viruses in vaccine cell substrates by chemical induction. Biologicals 2009, 37 (3), 196–201.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Weiss R.,
   2. Teich N.,
   3. Varmus H.,
   4. Coffin J.

   1. Coffin J. M.

   Endogenous Retroviruses. In RNA tumor viruses, 2nd ed.; Weiss R., Teich N., Varmus H., Coffin J., Eds.; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1984; Vol. 1, pp 1109–1203.

   OpenUrl
6. 6.↵
   1. Weiss R.,
   2. Teich N.,
   3. Varmus H.,
   4. Coffin J.

   1. Brown P. O.

   Integration. In Retroviruses; Weiss R., Teich N., Varmus H., Coffin J., Eds.; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1997; pp 161–203.
7. 7.↵
   1. Miller G.,
   2. Heston L.,
   3. Grogan E.,
   4. Gradoville L.,
   5. Rigsby M.,
   6. Sun R.,
   7. Shedd D.,
   8. Kushnaryov V. M.,
   9. Grossberg S.,
   10. Chang Y.

   Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 1997, 71 (1), 314–324.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   CBER. Guidance for industry: Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. U.S. FDA: Rockville, MD, February 2010.
9. 9.↵
   1. Ma H.,
   2. Ma Y.,
   3. Ma W.,
   4. Williams D. K.,
   5. Galvin T. A.,
   6. Khan A. S.

   Chemical induction of endogenous retrovirus particles from the Vero cell line of African green monkeys. J. Virol. 2011, 85 (13), 6579–6588.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Ma Y. K.,
    2. Khan A. S.

    Evaluation of different RT enzyme standards for quantitation of retroviruses using the single-tube fluorescent product-enhanced reverse transcriptase assay. J. Virol. Methods 2009, 157 (2), 133–140.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Lugert R.,
    2. Konig H.,
    3. Kurth R.,
    4. Tonjes R. R.

    Specific suppression of false-positive signals in the product-enhanced reverse transcriptase assay. Biotechniques 1996, 20 (2), 210–217.

    OpenUrlPubMed
12. 12.↵
    1. Franklin A.,
    2. Milburn P. J.,
    3. Blanden R. V.,
    4. Steele E. J.

    Human DNA polymerase-eta, an A-T mutator in somatic hypermutation of rearranged immunoglobulin genes, is a reverse transcriptase. Immunol. Cell Biol. 2004, 82 (2), 219–225.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. van der Kuyl A. C.,
    2. Dekker J. T.,
    3. Goudsmit J.

    Distribution of baboon endogenous virus among species of African monkeys suggests multiple ancient cross-species transmissions in shared habitats. J. Virol. 1995, 69 (12), 7877–7887.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. van der Kuyl A. C.,
    2. Mang R.,
    3. Dekker J. T.,
    4. Goudsmit J.

    Complete nucleotide sequence of simian endogenous type D retrovirus with intact genome organization: evidence for ancestry to simian retrovirus and baboon endogenous virus. J. Virol. 1997, 71 (5), 3666–3676.

    OpenUrlAbstract/FREE Full Text